"How to strengthen the biopharma ecosystem" : Commentary

By Roberto Gradnik, President of EBE and CEO of Stallergenes (Source: MedNous November/December 2013)

The sustainability of the biopharmapharmaceutical sector depends on a continual flow of new startups to both feed Big Pharma's pipelines and to create the next generation of emerging mid-cap companies.

(Read more: Attached document: Commentary EBE Gradnik Nov-Dec 2012.pdf)
Download | pdf 103.81 kB